Table 2.
Clinical Characteristics.
| Clinical Characteristics | COVID-19 (n = 37) |
Non-COVID-19 (n = 505) |
p |
|---|---|---|---|
| Delirium (NuDESC ≥ 2) | 19 (51.4%) | 333 (65.9%) | 0.073 |
| Delirium positive days (%) | 4.4 (0–65.2) | 39.1 (0–83.9) | 0.068 |
| ICU stay (days) | 10.6 (4.9–18.7) | 4.7 (2.9–8.1) | <0.001 |
| Mortality | 7 (18.9%) | 70 (13.9%) | 0.395 |
| TISS 10 * | 10 (10–15) | 10 (5–15); n = 503 | 0.270 |
| SAPS2 * | 43 (30–47) | 43 (34–52); n = 503 | 0.214 |
| Non-invasive ventilation | 28 (75.7%) | 202 (40.0%) | <0.001 |
| Invasive ventilation | 18 (48.6%) | 187 (37.0%) | 0.159 |
| Non-invasive or invasive ventilation | 33 (89.2%) | 298 (59.0%) | <0.001 |
| Days on ventilation ** | 14.3 (6.0–17.6) | 5.6 (2.3–9.3) | 0.006 |
| V-V ECMO | 5 (13.5%) | 10 (2.0%) | 0.002 |
| Catecholamine therapy | 25 (67.6%) | 294 (58.2%) | 0.265 |
| Norepinephrine | 25 (67.6%) | 277 (54.9%) | 0.133 |
| Dobutamine | 3 (8.1%) | 38 (7.5%) | 0.753 |
| Vasopressin | 2 (5.4%) | 22 (4.4%) | 0.675 |
| Renal replacement therapy | 5 (13.5%) | 63 (12.5%) | 0.798 |
| Necessity of blood transfusions | 16 (43.2%) | 177 (35.0%) | 0.315 |
| Cause of illness | |||
| Respiratory | 29 (78.4%) | 122 (24.2%) | <0.001 |
| Cardiac | 7 (18.9%) | 254 (50.3%) | <0.001 |
| Septic | 1 (2.7%) | 96 (19.0%) | 0.012 |
| Other | 0 (0.0%) | 79 (15.6%) | 0.009 |
Data given as absolute numbers n (% of all patients) or median and interquartile range (25th–75th). p-value reported in bold if difference is significant (p < 0.05). * at admission; ** only patients with invasive ventilation included. TISS 10: Therapeutic Intervention Scoring System 10; SAPS2: Simplified Acute Physiology Score 2; V-V ECMO: venovenous extracorporeal membrane oxygenation.